
Live Regeneron Pharmaceuticals Tokenized Stock (Ondo) price
Regeneron Pharmaceuticals Tokenized Stock (Ondo) price chart
Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon) price details

Regeneron Pharmaceuticals Tokenized Stock (Ondo) price history
Regeneron Pharmaceuticals Tokenized Stock (Ondo) technical analysis

Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon) sentiment
About Regeneron Pharmaceuticals Tokenized Stock (Ondo)
Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNON) Introduction
Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNON) represents a tokenized version of Regeneron Pharmaceuticals' stock, ticker REGN, on the blockchain. As per CoinMarketCap data extracted on March 31, 2026, its live price stands at $745.53 USD, with a 24-hour trading volume of $33,575.65 USD and a slight 0.92% decline. The token's market cap is $109.54 USD, with a circulating supply of about 0.147 REGNON coins and no maximum supply defined. Ranked #3719 on CoinMarketCap, REGNON offers synthetic exposure to Regeneron's performance in biotech, focusing on treatments for diseases like COVID-19 and eye conditions. Ondo Finance powers this by tokenizing assets, making them accessible globally via Ethereum, as seen on Etherscan. This setup appeals to crypto enthusiasts seeking diversified portfolios without traditional barriers.
How does Regeneron Pharmaceuticals Tokenized Stock (Ondo) Crypto Work?
Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNON) operates through Ondo Finance's tokenization protocol on the Ethereum blockchain. Users mint REGNON by depositing collateral, gaining exposure to REGN stock's price and dividends, which are automatically reinvested. This synthetic asset mirrors REGN's performance via smart contracts, ensuring 24/5 liquidity from traditional exchanges. As explained in Ondo Finance's documentation, restrictions apply to US persons for regulatory compliance. The token's value tracks Regeneron's stock, influenced by biotech innovations like monoclonal antibodies. Blockchain explorers like Etherscan verify transactions, promoting transparency. Unlike direct stock ownership, REGNON avoids voting rights but offers crypto advantages like fast settlements. Critics note potential oracle risks for price feeds, yet Ondo's secure design, audited by firms like PeckShield, addresses these, making it a reliable RWA tool.
Regeneron Pharmaceuticals Tokenized Stock (Ondo) (token ticker REGNON) Price Prediction
Forecasting the price of Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNON) involves analyzing its tie to REGN stock and broader market trends. Current data from CoinMarketCap shows REGNON at $745.53 USD, down 0.92% in 24 hours, reflecting biotech sector fluctuations. Analysts like those at Seeking Alpha predict REGN could rise 15-20% in 2026, driven by pipeline drugs, potentially boosting REGNON similarly. However, crypto volatility adds risks. For a detailed Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNON) price prediction and forecast, visit WEEX to explore current data and future outlooks. Remember, predictions aren't guarantees; factors like regulatory changes or market downturns could impact values.
How Do You Buy Regeneron Pharmaceuticals Tokenized Stock (Ondo) (Abbreviation REGNON)?
Buying Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNON) starts with selecting a reliable exchange. First, register on WEEX or log in on WEEX if you have an account. Once set up, deposit funds like USDT. Search for the REGNON/USDT pair and place a buy order at market or limit price. For step-by-step guidance, check out this how to buy Regeneron Pharmaceuticals Tokenized Stock (Ondo) guide on WEEX. Always verify wallet compatibility with Ethereum, as REGNON is ERC-20. Don't forget to enable two-factor authentication for security. Start small to understand fees and market dynamics before larger investments.
Official links
Social media and community
FAQ
1. What is the current price of Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon) in USD?
2. What is the market capitalization of Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon)?
3. What is the circulating supply of Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon)?
4. What factors influence the price of Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon)?
5. Is Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon) a good investment?
6. Where can I buy Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon)?
7. What are the typical fees when buying Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon)?
8. What are some technical indicators used for analyzing Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon)?
Currency price converter
Popular
Global prices
¥
₽
€
$
¥
NT$
₫
aed
₴
zł
R$
Rp
$
₼Regeneron Pharmaceuticals Tokenized Stock (Ondo) news
Morning News | The draft amendment to the People's Bank of China Law aims to clarify the legal status of digital renminbi; South Korea will transfer about 40 unregistered virtual asset service providers to law enforcement agencies
Overview of Important Market Events on June 24
The cryptocurrency industry has entered the "Show Me" era: merely relying on vision is no longer enough
The awareness level of the audience in the cryptocurrency industry—including media, institutions, and retail investors—is steadily increasing, and this trend has become a foregone conclusion.
Interpreting the Ethereum Foundation's new structure: Reaffirming self-sovereignty amid institutional trends
The Ethereum Foundation has announced a new five-layer working framework, clarifying the focus of future development and reaffirming its commitment to decentralized core values amidst the wave of institutionalization.
Former SpaceX engineer reconstructs the financial execution system using first principles
Plan Execution Lab completes angel round financing for Singapore family office, with a valuation of 50 million USD.
Tidal Investment: We still have a positive outlook on the AI industry chain, but the reasons have changed
The intense financing by tech giants has triggered a panic of "AI peak," but the soaring capital expenditures of the five major cloud vendors and the bottlenecks in physical infrastructure indicate that the AI investment cycle is far from over; the second half of this grand performance has just begu...
Standard Chartered Bank sings a 50x rhapsody again, aiming for AAVE to reach 3500 USD
The throne of DeFi lending still exists, but the foundation beneath the throne needs to undergo a reconstruction or reinforcement.
Website
X(Twitter)











